{"id":44592,"date":"2022-06-01T23:01:26","date_gmt":"2022-06-01T21:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/"},"modified":"2022-06-01T23:01:26","modified_gmt":"2022-06-01T21:01:26","slug":"sqz-biotechnologies-to-present-at-jefferies-healthcare-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/","title":{"rendered":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference"},"content":{"rendered":"<div>\n<p>WATERTOWN, Mass.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fsqzbiotech.com%2F&amp;esheet=52736851&amp;newsitemid=20220601006003&amp;lan=en-US&amp;anchor=SQZ+Biotechnologies&amp;index=1&amp;md5=0cc64d4e93b825bf437e8f1536aed6aa\" rel=\"nofollow noopener\" shape=\"rect\">SQZ Biotechnologies<\/a> (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Jefferies Healthcare Conference on June 8, in New York, NY. Presentation time and webcast information is available below.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/5\/SQZ_Logo-Medium.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg\"><\/a><\/p>\n<p>\n<b>PRESENTATION DETAILS<\/b>\n<\/p>\n<p>\n<b>Wednesday, June 8<br \/>\n<br \/><\/b><i>Jefferies Healthcare Conference<br \/>\n<br \/><\/i>2:30-2:55 p.m. ET<br \/>\n<br \/><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Fjeff240%2Fsqz%2F1729950&amp;esheet=52736851&amp;newsitemid=20220601006003&amp;lan=en-US&amp;anchor=Webcast&amp;index=2&amp;md5=07ce4973c61d1c344338696d14a31ad1\" rel=\"nofollow noopener\" shape=\"rect\">Webcast<\/a>\n<\/p>\n<p>\nConference webcast details and the company\u2019s most recent corporate overview presentation will be available on the Investors section of the SQZ <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.sqzbiotech.com%2Foverview%2Fdefault.aspx&amp;esheet=52736851&amp;newsitemid=20220601006003&amp;lan=en-US&amp;anchor=website&amp;index=3&amp;md5=75beb29b917c76bcb15858ff899b1098\" rel=\"nofollow noopener\" shape=\"rect\">website<\/a>. Replay will be available for 90 days.\n<\/p>\n<p>\nBased on guidance from the SEC, investors should note that the company may announce future healthcare conference presentations on the Events &amp; Presentations page of the Investor Relations section of its corporate website, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Finvestors.sqzbiotech.com%2Foverview%2Fdefault.aspx&amp;esheet=52736851&amp;newsitemid=20220601006003&amp;lan=en-US&amp;anchor=investors.sqzbiotech.com&amp;index=4&amp;md5=af2af83a82cf58c2ea5ef50651973d86\" rel=\"nofollow noopener\" shape=\"rect\">investors.sqzbiotech.com<\/a>. It is possible that the information posted there could be deemed to be material information.\n<\/p>\n<p>\n<b>About SQZ Biotechnologies<\/b>\n<\/p>\n<p>\nSQZ Biotechnologies Company is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies for patients around the world. The company has active programs in oncology, autoimmune and infectious diseases, as well as additional exploratory initiatives to support future pipeline growth. SQZ\u2019s proprietary Cell Squeeze\u00ae technology can deliver multiple biological materials into many cell types, offering the ability to engineer a broad range of potential therapeutics. With clinical production timelines already under 24 hours, the company has the potential to enable broader patient accessibility through point-of-care manufacturing implementation across multiple therapeutic programs. Our approach could also improve a patient\u2019s treatment journey with no planned hospitalization or preconditioning treatment. The company\u2019s first therapeutic efforts seek to generate target-specific immune responses, both through activation for the treatment of solid tumors and infectious diseases, and by immune tolerance for the treatment of autoimmune diseases. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sqzbiotech.com%2F&amp;esheet=52736851&amp;newsitemid=20220601006003&amp;lan=en-US&amp;anchor=www.sqzbiotech.com&amp;index=5&amp;md5=407868fcb15dfaa0a2f1f551e07e4e5b\" rel=\"nofollow noopener\" shape=\"rect\">www.sqzbiotech.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor:<\/b><br \/>Mike Kaiser<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6d;i&#x63;h&#x61;e&#x6c;&#46;&#107;&#x61;&#105;&#x73;&#101;&#x72;&#64;&#x73;&#113;&#x7a;b&#x69;o&#x74;e&#x63;h&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#105;c&#x68;&#97;e&#x6c;&#46;k&#x61;&#105;s&#x65;&#114;&#64;&#x73;&#113;z&#x62;&#105;o&#x74;&#101;c&#x68;&#46;c&#x6f;&#109;<\/a><br \/>857-760-0398\n<\/p>\n<p>\n<b>Media:<\/b><br \/>John Lacey<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x6a;&#111;&#104;&#x6e;&#x2e;&#108;&#97;&#x63;&#x65;&#121;&#64;&#x73;&#x71;&#122;&#98;&#x69;&#x6f;&#116;&#101;&#x63;&#x68;&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6a;&#x6f;&#x68;&#110;&#46;la&#x63;&#x65;&#x79;&#x40;&#115;&#113;zb&#x69;&#x6f;&#x74;&#101;&#99;&#104;&#46;c&#x6f;&#x6d;<\/a><br \/>781-392-5514\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass.&#8211;(BUSINESS WIRE)&#8211;SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Jefferies Healthcare Conference on June 8, in New York, NY. Presentation time and webcast information is available below. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44592","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass.&#8211;(BUSINESS WIRE)&#8211;SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Jefferies Healthcare Conference on June 8, in New York, NY. Presentation time and webcast information is available below. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-01T21:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"SQZ Biotechnologies to Present at Jefferies Healthcare Conference\",\"datePublished\":\"2022-06-01T21:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/\"},\"wordCount\":334,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006003\\\/en\\\/1413125\\\/21\\\/SQZ_Logo-Medium.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/\",\"name\":\"SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006003\\\/en\\\/1413125\\\/21\\\/SQZ_Logo-Medium.jpg\",\"datePublished\":\"2022-06-01T21:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006003\\\/en\\\/1413125\\\/21\\\/SQZ_Logo-Medium.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006003\\\/en\\\/1413125\\\/21\\\/SQZ_Logo-Medium.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SQZ Biotechnologies to Present at Jefferies Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend","og_description":"WATERTOWN, Mass.&#8211;(BUSINESS WIRE)&#8211;SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today announced that Armon Sharei, Ph.D., Chief Executive Officer and Founder of SQZ Biotechnologies, will present at the Jefferies Healthcare Conference on June 8, in New York, NY. Presentation time and webcast information is available below. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-01T21:01:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference","datePublished":"2022-06-01T21:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/"},"wordCount":334,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/","url":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/","name":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg","datePublished":"2022-06-01T21:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220601006003\/en\/1413125\/21\/SQZ_Logo-Medium.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sqz-biotechnologies-to-present-at-jefferies-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"SQZ Biotechnologies to Present at Jefferies Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44592"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44592\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}